There is a newer version
of
this Section
2017 Maryland Code
Health - General
Title 21 - Food, Drugs, and Cosmetics
Subtitle 2B - Right to Try Act.
§ 21-2B-03. Actions prohibited if based on recommendation regarding access to or treatment with an investigational drug, biological product, or device.
Universal Citation: MD Health-Gen Code § 21-2B-03 (2017)
- (a) Action by board against health care provider prohibited. -- A health occupations board may not revoke, fail to renew, suspend, or take any action against a health care provider's license based solely on the health care provider's recommendation to an eligible patient regarding access to or treatment with an investigational drug, biological product, or device.
- (b) Action by Department against health care provider prohibited. -- The Department may not take action against a health care provider's Medicare certification based solely on the health care provider's recommendation that an eligible patient have access to an investigational drug, biological product, or device or the health care provider's treatment of an eligible patient with an investigational drug, biological product, or device.
Disclaimer: These codes may not be the most recent version. Maryland may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
